State Key Laboratory of Oncology in Southern China, Department of Experimental Research, Cancer Center, Sun Yat-sen University, Guangzhou, Guangdong, China.
Gastroenterology. 2012 Oct;143(4):995-1005.e12. doi: 10.1053/j.gastro.2012.06.033. Epub 2012 Jun 23.
BACKGROUND & AIMS: The flotillin family of proteins, including flotillin-1 (FLOT1 or Reggie-2), are lipid raft proteins that initiate receptor kinase signaling and are up-regulated in several tumor types. We investigated the role of FLOT1 signaling and activation of the transcription factor nuclear factor (NF)-κB in esophageal squamous cell carcinoma (ESCC) cells.
We used immunoblot and immunochemical analyses to determine levels of the lipid raft-associated protein FLOT1 in ESCC cell lines and 432 ESSC samples from patients; primary normal esophageal epithelial cells and matched adjacent nontumor tissues were used as controls. We determined the ability of FLOT1 to activate NF-κB using kinase, electrophoretic mobility shift, and luciferase reporter assays. We measured the effects of FLOT1 overexpression and knockdown with short hairpin RNAs in ESCC cell lines using colony formation, anchorage-independent growth, chicken chorioallantoic membrane, transwell matrix penetration, and Annexin V-binding assays. We analyzed growth of ESCC xenograft tumors in nude mice.
Levels of FLOT1 were increased in ESCC cell lines and samples from patients, compared with controls; protein levels correlated with disease stage and survival time. Overexpression of FLOT1 in Kyse30 and Kyse510 ESCC cell lines increased proliferation, anchorage-independent growth, and invasive activity and protected them from apoptosis. FLOT1-transduced ESCC cells formed larger tumors in nude mice than control cells (transduced with only the vector). FLOT1 facilitated recruitment of the tumor necrosis factor-α receptor to lipid rafts; promoted K63-linked polyubiquitination of the signaling intermediaries tumor necrosis factor receptor associated factor 2, receptor interacting protein, and NEMO; and sustained the activation of NF-κB. Levels of FLOT1 correlated with activation of NF-κB in ESCC samples from patients.
The lipid raft protein FLOT1 is up-regulated in ESCC cell lines and samples from patients and promotes ESCC cell proliferation and tumor growth in mice. FLOT1 activates tumor necrosis factor-α receptor signaling and sustains activation of NF-κB in ESCC cells.
Flotillin 蛋白家族,包括 flotillin-1(FLOT1 或 Reggie-2),是脂筏蛋白,可启动受体激酶信号,并在几种肿瘤类型中上调。我们研究了 FLOT1 信号转导和转录因子核因子(NF)-κB 在食管鳞状细胞癌(ESCC)细胞中的作用。
我们使用免疫印迹和免疫化学分析来确定 ESCC 细胞系和 432 例患者 ESCC 样本中脂筏相关蛋白 FLOT1 的水平;原代正常食管上皮细胞和匹配的相邻非肿瘤组织作为对照。我们使用激酶、电泳迁移率变动和荧光素酶报告基因测定来确定 FLOT1 激活 NF-κB 的能力。我们使用短发夹 RNA 在 ESCC 细胞系中测量 FLOT1 过表达和敲低的影响,使用集落形成、无锚定生长、鸡绒毛尿囊膜、Transwell 基质渗透和 Annexin V 结合测定。我们分析了裸鼠中 ESCC 异种移植肿瘤的生长。
与对照组相比,FLOT1 水平在 ESCC 细胞系和患者样本中升高;蛋白水平与疾病分期和生存时间相关。在 Kyse30 和 Kyse510 ESCC 细胞系中过表达 FLOT1 可增加增殖、无锚定生长和侵袭活性,并保护它们免受凋亡。与对照细胞(仅转导载体)相比,FLOT1 转导的 ESCC 细胞在裸鼠中形成更大的肿瘤。FLOT1 促进肿瘤坏死因子-α受体向脂筏募集;促进信号中介物肿瘤坏死因子受体相关因子 2、受体相互作用蛋白和 NEMO 的 K63 连接多泛素化;并维持 NF-κB 的激活。ESCC 患者样本中 FLOT1 的水平与 NF-κB 的激活相关。
脂筏蛋白 FLOT1 在 ESCC 细胞系和患者样本中上调,并促进 ESCC 细胞增殖和小鼠肿瘤生长。FLOT1 在 ESCC 细胞中激活肿瘤坏死因子-α受体信号,并维持 NF-κB 的激活。